Yihua Health Medical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
The Company held its first meeting of the ninth Board of Directors on May 19, 2023, where it reviewed and approved the proposal on the appointment of a sponsor securities firm, agreeing to appoint Wanhe Securities Co., Ltd. (hereinafter referred to as "Wanhe Securities") as the Company's sponsor securities firm. The specific circumstances are announced as follows:
1. Explanation of the Appointment of the Sponsor Securities Firm
The Company received a prior notice from the Shenzhen Stock Exchange on April 28, 2023. If the Company's stock is subsequently decided to be delisted by the Shenzhen Stock Exchange, according to the relevant provisions of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)" and the "Implementation Measures for Delisted Companies Entering the Delisting Sector for Transfer," the Company's stock will be transferred to the delisting sector managed by the National Equities Exchange and Quotations.
According to the relevant provisions of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," the Company must appoint a securities firm qualified to act as a sponsor securities firm (hereinafter referred to as "sponsor securities firm") and sign relevant agreements with it. The first meeting of the ninth Board of Directors reviewed and approved the appointment of Wanhe Securities as the Company's sponsor securities firm and signed the "Entrusted Stock Transfer Agreement," entrusting it to provide share transfer services for the Company, handle the stock exchange market registration and settlement system's stock exit registration, manage stock re-confirmation, and handle related matters such as stock registration and settlement in the National Small and Medium Enterprises Share Transfer System.